AAPM joined other pain groups in protesting the proposed expansion of a CMS rule that would increase prior authorization requirements for implanted spinal neurostimulators to curb potential unnecessary utilization. Full letter.

Related Posts

Oct. 24: National Prescription Drug Take Back Day

Published On:

AAPM Signs Letter Opposing CMS Expansion for Pre-Approval for Neurostimulator Implantation

Published On:

FDA Approvals of Opioids Based on Insufficient Efficacy and Safety Data

Published On: